Transthyretin Amyloid Polyneuropathy Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Transthyretin Amyloid Polyneuropathy
Transthyretin amyloid polyneuropathy (ATTR-PN) is a rare, progressive condition causing nerve damage due to protein misfolding. Managing ATTR-PN often involves specialized, high-cost medications. TheDrugClub helps individuals and families afford these vital treatments by offering significant prescription discounts, making it easier to access the care you need without financial strain.
Transthyretin amyloid polyneuropathy (ATTR-PN) is a serious and progressive condition resulting from the buildup of abnormal transthyretin (TTR) protein deposits, called amyloid, in the nerves and other tissues. Normally, TTR helps transport thyroid hormones and vitamin A throughout the body. However, in ATTR-PN, the TTR protein misfolds and aggregates, forming amyloid fibrils that accumulate, primarily affecting the peripheral and autonomic nervous systems.
This amyloid deposition leads to a range of symptoms that can significantly impact daily life. Patients often experience sensory neuropathy (numbness, tingling, pain), motor weakness (difficulty walking, grasping), and autonomic neuropathy, which can affect digestion, blood pressure regulation, and heart function. The condition can be inherited (hereditary ATTR-PN) or develop without a genetic cause (wild-type ATTR-PN), typically later in life. Early diagnosis is crucial for slowing its progression and managing symptoms.
Treating ATTR-PN focuses on slowing or stopping the amyloid deposition and managing symptoms. Current treatments include medications that stabilize the TTR protein, preventing it from misfolding (e.g., tafamidis, diflunisal), or those that reduce the production of the TTR protein itself (e.g., patisiran, inotersen). These advanced therapies have shown promise in improving patient outcomes, but they often come with a very high price tag, posing a significant financial burden for many patients and their families. Additionally, patients may require other medications to manage specific symptoms like pain, gastrointestinal issues, or heart problems.
This is where TheDrugClub steps in. We understand that the cost of necessary medications can be a major barrier to effective treatment. TheDrugClub is a prescription savings membership program designed to help you access your medications at a lower price. With a Drug Club membership, members gain access to discounted prices on thousands of prescription drugs, including many specialty medications used for conditions like ATTR-PN. It's not insurance, but a straightforward way to save money on your prescriptions, whether you have insurance or not.
Joining is simple
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.